Hope Bancorp heads into its third-quarter report with a business that looks healthier than its stock price suggests. Last quarter, management delivered rising margins, loan growth that picked back up and a steadily improving efficiency ratio. Yet the shares have slipped since then while the broader market climbed, and trader sentiment has turned noticeably sour. That gap between operating momentum and market enthusiasm is the real story heading into the October 28 release, which arrives before the opening bell.
The Street expects earnings of $0.30 a share, up from $0.27 last quarter and about 20% above the year-ago figure. That would extend a clear upward run in core profitability. The consensus revenue estimate of $152.6 million implies a 41% year-over-year drop, but that comparison should not be taken at face value. The forecast appears to reflect net revenue, essentially net interest income plus fees, while the prior-period totals look to be measured on a broader basis. Nothing management said last quarter points to a collapse in the top line. If anything, the company reaffirmed a full-year outlook calling for revenue growth of 15% to 20%, roughly 20% loan growth and a 25% to 30% jump in pre-provision net revenue. Those targets include one quarter of the pending Manubank acquisition, so the third quarter is mostly a test of the organic engine.
The net interest margin is the first place to look. It rose to 2.96% in the second quarter, and management said it exited June at 2.98% while guiding to expansion of a few basis points each quarter as higher-cost CDs reprice lower. A margin at or modestly above 3% would confirm that thesis. A stall would raise questions, especially since new deposits are still costing 350 to 380 basis points and management has acknowledged that reducing its heavy reliance on CDs will be slow. Deposit mix deserves attention too. Some of last quarter's growth in noninterest-bearing deposits came from one-time tariff refunds, so a drop in those balances would not be alarming on its own. A sharp outflow that pushes funding costs higher would be a concern.
Loan growth is the second test. Balances grew at an 8% annualized pace to $15.0 billion after a flat first quarter, led by commercial and industrial lending. Management described its pipelines as active. Another quarter of mid-to-high single-digit growth would show the rebound was real and not just timing. Fee income offers a smaller but useful check. SBA gains reached $4 million last quarter, and hitting the full-year target of $16 million to $17 million requires a slightly faster second half. Credit also bears watching. Net charge-offs eased to 24 basis points as the bank worked through previously identified problem loans, and criticized loans fell 19% from a year earlier. Further improvement would remove a lingering overhang.
Then there is Manubank. The all-cash deal adds roughly $2.3 billion in loans and $2.6 billion in deposits, and it comes with a partnership to serve Japanese companies and consumers in the U.S. Any update on regulatory approvals and closing timing matters, because the full-year guidance assumes the deal contributes in the fourth quarter. A delay would mechanically pressure that outlook.
The stock sits at $13.34, above its 200-day moving average but near the bottom of its post-earnings range of $13.00 to $14.59. Sentiment has swung from mildly bullish before last quarter's report to clearly bearish now. That combination suggests a low bar. If Hope shows the margin still moving toward 3%, keeps loan growth intact and confirms the Manubank timeline, the improving narrative from last quarter survives. If any of those three falter, the skeptics will have their evidence.